Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) announced it will report financial results for the third quarter ended September 30, 2026, before the market opens on November 6, 2026. The cannabis company plans to host a conference call and webcast to discuss these results and provide key business highlights to investors.

Event Details

The earnings conference call is scheduled for the morning of the release date. Investors can access the live webcast through a registration link provided by the company. Archived access to the webcast will remain available for one year on the Cresco Labs investor relations website.

Company Profile

Cresco Labs describes itself as an industry leader in branded cannabis products and the operator of Sunnyside dispensaries. The company’s mission involves normalizing and professionalizing the cannabis industry through a consumer packaged goods approach to building national brands. Its portfolio includes brands such as Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s, and Remedi.

The company operates highly productive dispensaries nationally under the Sunnyside brand, focusing on patient and consumer trust. Cresco Labs also engages in legislative and regulatory initiatives through its SEED initiative efforts.

Cresco Labs Inc. (CSE: CL) filed a supplement to its management information circular ahead of its annual general and special meeting scheduled for October 30, 2026. The filing clarifies disclosures regarding proposed amendments to super-voting shares and related minority approval requirements.

Meeting details and voting deadlines

The annual general and special meeting will be held via live audio webcast at 12:00 pm Central Daylight Time on Friday, October 30, 2026. Shareholders of record as of the close of business on September 15, 2026, are entitled to receive notice and vote at the meeting.

Proxies must be received by 12:00 pm Central Daylight Time on Wednesday, October 28, 2026, or two business days before any adjourned or postponed meeting. Beneficial shareholders holding through an intermediary must follow the specific voting instructions provided by that intermediary, which may impose an earlier deadline.

Accessing filings

The Supplement, the original Circular dated September 18, 2026, and related materials are available under the company’s profile on SEDAR+ and EDGAR. They are also accessible on the Cresco Labs website.

Solicitation participants

The company and its directors, executive officers, and other members of management may be deemed participants in the solicitation of proxies from shareholders regarding matters to be considered at the meeting. Information regarding these persons, including their direct and indirect interests by security holdings, is set forth in the Circular and other filings available on SEDAR+ and EDGAR.

This press release does not constitute an offer to sell or the solicitation of an offer to buy or exchange any securities, nor a solicitation of any vote or approval in any jurisdiction.